Investigation of the Contents and Prognostic Values of Glucose Metabolism Molecules in Patients With Lung Adenocarcinoma
NCT03641105 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2018-08-21
Summary
Detect the contents of glucose metabolism molecules in the tumor and adjacent normal samples of about 100 patients with lung adenocarcinoma using mass spectroscopy. Analyze the correlation between the contents and the clinicopathological characteristics and survival.
Conditions
- Lung Cancer
- Glycolysis
- Diagnosis
- Survival
Interventions
- DIAGNOSTIC_TEST
-
Diagnostic test
detect the contents of glucose metabolism molecules using mass spectrum
Sponsors & Collaborators
-
Shanghai Zhongshan Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-01
- Primary Completion
- 2019-03-01
- Completion
- 2019-03-01
More Related Trials
-
The Alterations of Metabolic Adipo-myokines and Body Composition in End Stage Lung Cancer
NCT06060262 ·Status: RECRUITING
-
A Study of the Gene Mutation Status in Cerebrospinal Fluid, Blood and Tumor Tissue of Non-small Cell Lung Cancer Patients With Brain Metastases
NCT03257735 ·Status: UNKNOWN
-
Glucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With Targeted Therapy and Chemotherapy
NCT00450567 ·Status: COMPLETED
-
Clinical Study on the Prevention of Driver Gene Negative Ib-IIIb Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors
NCT05834413 ·Status: RECRUITING ·Phase: NA
-
Bronchoscopy Screening for High-risk Population of Lung Cancer With Severe Smoking With Negative LDCT Screen
NCT04413669 ·Status: UNKNOWN ·Phase: NA
-
CTC in Lung Caner Patients With Bone Metastases
NCT04568291 ·Status: UNKNOWN ·Phase: NA
-
Research of the EML4-ALK Gene Expression in the Pleural Effusion or Tumor Tissue From Lung Cancer Patients
NCT01257308 ·Status: UNKNOWN
-
cfDNA Methylation Assay for Clinical Evaluation of Patients With Stage IA Lung Cancer After Ablation Operation
NCT04413656 ·Status: UNKNOWN ·Phase: NA
-
Molecular Profiling in Small Cell Lung Cancer
NCT03162705 ·Status: UNKNOWN
-
ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS
NCT03172156 ·Status: COMPLETED
-
Effect of Compound Amino Acid Tablets on Nutritional Status of Patients With Lung Cancer
NCT05770063 ·Status: UNKNOWN ·Phase: NA
-
The Establishment and Clinical Application of a Prediction Model of Lung Cancer Distant Metastasis Based on the Genomic Characteristics of Circulating Tumor Cells
NCT04568720 ·Status: UNKNOWN
-
Integrative Analysis of Large-cell Lung Cancer
NCT02917369 ·Status: RECRUITING
-
Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung Cancer
NCT02941003 ·Status: UNKNOWN ·Phase: NA
-
Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung Adenocarcinoma
NCT05830812 ·Status: RECRUITING
-
Metformin in Stage IV Lung Adenocarcinoma
NCT01997775 ·Status: TERMINATED ·Phase: PHASE2
-
Lung Function Testing in Patients With Locally Advanced or Metastatic Solid Tumors
NCT00914147 ·Status: COMPLETED ·Phase: NA
-
Gene Mutations in Non-Small Cell Lung Cancer Cells
NCT00977509 ·Status: UNKNOWN
-
Novel Detection System for Lung Cancer Curative Effect Monitoring
NCT02666755 ·Status: UNKNOWN
-
Multicenter Observational Study of Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Rare Driver Gene Mutation
NCT04137718 ·Status: UNKNOWN
-
Identify Prognostic Biomarkers of Lung Cancer
NCT05010330 ·Status: UNKNOWN
-
A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis
NCT02803619 ·Status: UNKNOWN
-
Study of the Correlation of Tumor Tissue Microbiome to the Pathogenesis of Lung Cancer
NCT04260295 ·Status: UNKNOWN
-
Development and Application of Molecular Evaluation Instrument for Lung Cancer Diagnosis and Treatment
NCT06086587 ·Status: NOT_YET_RECRUITING
-
A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC
NCT06443684 ·Status: RECRUITING